Mesalazine tablets for Europe Market [RSABE / ABEL]

posted by komodo – Turkey, 2015-10-23 10:52 (3404 d 09:25 ago) – Posting: # 15576
Views: 7,919

❝ We would like to know what kind of studies required for Mesalazine Gastro-resistant MR tablets for Europe Market.


Dear Kotu,

Since it has enteric coated form most probably it will require semi or fully replicate design but to decide it better to perform a pilot study with 18 sub at least to have a meaningful results. as per literature sources ISCV >30% :confused:


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,663 registered users;
46 visitors (0 registered, 46 guests [including 8 identified bots]).
Forum time: 19:17 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5